In the second edition of ΢²ªÊÓƵ LIVE: COVID-19, two ΢²ªÊÓƵ clinicians will talk about and take questions on the new treatments for COVID-19 being tested at ΢²ªÊÓƵ Health and other hospitals, including the experimental antiviral drug remdesivir — used to treat ΢²ªÊÓƵ’ first patient of the pandemic in March — and using plasma from people who have recovered from the novel coronavirus to treat patients.
MORE CORONAVIRUS EXPERTISE
The guests are Sarah Barnhard, director of transfusion medicine and assistant clinical professor in the Department of Pathology and Laboratory Medicine; and Stuart Cohen, professor of internal medicine and chief of the Division of Infectious Diseases.
The conversation, hosted by Soterios Johnson, will be streamed live on and beginning at 11 a.m. Thursday (May 21).
Questions can be submitted via either in advance or during the show.
Watch the first edition of ΢²ªÊÓƵ LIVE: COVID-19, below.
Media Resources
Carole Gan, ΢²ªÊÓƵ Health Public Affairs, 916-734-9047, cfgan@ucdavis.edu
Andy Fell, ΢²ªÊÓƵ News and Media Relations, 530-752-4533, ahfell@ucdavis.edu